Fexofenadine: predictive factors of efficacy in allergic rhinitis

M. Aubier, D. Charpin, C. Dubreuil, T. Abdelhadi, A. Richard, F. Neukirch (Paris, Marseille, Lyon, Massy, France)

Source: Annual Congress 2001 - Cellular immunopathology of rhinitis and asthma
Session: Cellular immunopathology of rhinitis and asthma
Session type: Thematic Poster Session
Number: 1821
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Aubier, D. Charpin, C. Dubreuil, T. Abdelhadi, A. Richard, F. Neukirch (Paris, Marseille, Lyon, Massy, France). Fexofenadine: predictive factors of efficacy in allergic rhinitis. Eur Respir J 2001; 16: Suppl. 31, 1821

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The efficacy of desloratadine in the treatment of allergic rhinitis
Source: Eur Respir J 2004; 24: Suppl. 48, 124s
Year: 2004

Efficacy and safety of levocetirizine in persistent allergic rhinitis (PER)
Source: Eur Respir J 2005; 26: Suppl. 49, 136s
Year: 2005

The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 124s
Year: 2004

Efficacy of montelukast in patients with concomitan persistent allergic rhinitis and asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 663s
Year: 2006

The effect of cockroach-sensitivity on allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 436s
Year: 2001

Clinical relevance of anti-inflammatory treatment of rhinitis for the course and prognosis of allergic bronchial asthma
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007


Levocetirizine and montelukast in the treatment of seasonal allergic rhinitis
Source: Eur Respir J 2005; 26: Suppl. 49, 137s
Year: 2005

Budesonide and loratadine in the treatment of allergic rhinitis in children
Source: Eur Respir J 2003; 22: Suppl. 45, 134s
Year: 2003

Effect of adding montelukast on asthma and rhinitis in asthma patients with concomitant allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 121s
Year: 2006

Is montelukast effective in allergic rhinitis in children?
Source: Eur Respir J 2006; 28: Suppl. 50, 263s
Year: 2006

Efficacy and safety of ciclesonide in the treatment of patients with persistent allergic or non-allergic asthma
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012

Risk factors of bronchial asthma in allergic rhinitis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 372s
Year: 2003

Local cytokine profile specifics among patients with BA phenotype, associated to allergic rhinitis: allergic rhinitis and bronchial asthma.
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018

Budesonide nasal spray alone or in combination with cetirizine in patients with severe seasonal allergic rhinitis and asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 45s
Year: 2002

Effects of loratadine and its generic on symptoms of asthma and rhinitis
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008


The diagnostic value of biomarkers in allergic and non-allergic asthma phenotype
Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Year: 2018


Treatment and outcomes in patients with asthma and allergic rhinitis
Source: Eur Respir J 2005; 26: Suppl. 49, 576s
Year: 2005

The role of omalizumab or rhuMAb-E25 in the treatment of allergic rhinitis
Source: Eur Respir J 2004; 24: 330
Year: 2004


Levocetirizine in the treatment of perennial allergic rhinitis
Source: Eur Respir J 2002; 20: Suppl. 38, 526s
Year: 2002

Does treatment of allergic rhinitis with intranasal steroids improve asthma control
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008